Trial Profile
Specified Drug-use Survey of Fomepizole Intravenous Infusion "Takeda" (All-case Surveillance)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2024
Price :
$35
*
At a glance
- Drugs Fomepizole (Primary)
- Indications Ethylene glycol poisoning; Methanol poisoning
- Focus Adverse reactions; Therapeutic Use
- Sponsors Takeda
- 12 Jul 2022 Status changed from active, no longer recruiting to completed.
- 27 Mar 2022 Status changed from recruiting to active, no longer recruiting.
- 26 Jul 2018 Planned End Date changed from 1 Jul 2022 to 30 Jun 2022.